Dr. Martens plc Short Interest Down 8.2 percent in June - Defense World

DOCMF Stock  USD 0.70  0.07  9.09%   
Roughly 61% of Dr Martens' investor base is looking to short. The analysis of overall sentiment of trading Dr Martens plc pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Dr Martens' historical and current headlines, can help investors time the market. In addition, many technical investors use Dr Martens plc stock news signals to limit their universe of possible portfolio assets.
Dr Martens pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of DOCMF daily returns and investor perception about the current price of Dr Martens plc as well as its diversification or hedging effects on your existing portfolios.
  
Dr. Martens plc Short Interest Down 8.2 percent in June Defense World

Read at news.google.com
Google News at Macroaxis
  

Dr Martens Fundamental Analysis

We analyze Dr Martens' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Martens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Martens based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Dr Martens is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Dr Martens plc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dr Martens pink sheet to make a market-neutral strategy. Peer analysis of Dr Martens could also be used in its relative valuation, which is a method of valuing Dr Martens by comparing valuation metrics with similar companies.

Complementary Tools for DOCMF Pink Sheet analysis

When running Dr Martens' price analysis, check to measure Dr Martens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Martens is operating at the current time. Most of Dr Martens' value examination focuses on studying past and present price action to predict the probability of Dr Martens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Martens' price. Additionally, you may evaluate how the addition of Dr Martens to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments